Long-term results of combination therapy using anti-VEGF agents and dexamethasone intravitreal implant for retinal vein occlusion: an investigational case series

References

• RehakMWiedemannPRetinal vein thrombosis: pathogenesis and managementJ Thromb Haemost2010891886189420492457
   PubMed Web of Science ®Google Scholar
• PielenAFeltgenNIsserstedtCCallizoJJunkerBSchmuckerCEfficacy and safety of intravitreal therapy in macular edema due to branch and central retinal vein occlusion: a systematic reviewPLoS One2013810e7853824205253
   PubMed Web of Science ®Google Scholar
• ChatziralliINicholsonLSivaprasadSHykinPIntravitreal steroid and anti-vascular endothelial growth agents for the management of retinal vein occlusion: evidence from randomized trialsExpert Opin Biol Ther201515121685169726358547
   PubMed Web of Science ®Google Scholar
• LipPLMalickHDamerKOne-year outcome of bevacizumab therapy for chronic macular edema in central and branch retinal vein occlusions in real-world clinical practice in the UKClin Ophthalmol201591779178426445525
   PubMedGoogle Scholar
• IpMSScottIUVanVeldhuisenPCA randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5Arch Ophthalmol200912791101111419752419
   PubMedGoogle Scholar
• ScottIUIpMSVanVeldhuisenPCA randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6Arch Ophthalmol200912791115112819752420
   PubMedGoogle Scholar
• BrownDMCampochiaroPABhisitkulRBSustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III studyOphthalmology201111881594160221684606
   PubMed Web of Science ®Google Scholar
• CampochiaroPABrownDMAwhCCSustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III studyOphthalmology2011118102041204921715011
   PubMed Web of Science ®Google Scholar
• HallerJABandelloFBelfortRJrDexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion: twelve-month study resultsOphthalmology2011118122453246021764136
   PubMed Web of Science ®Google Scholar
• BrownDMHeierJSClarkWLIntravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS studyAm J Ophthalmol2013155342943723218699
   PubMed Web of Science ®Google Scholar
• CampochiaroPAClarkWLBoyerDSIntravitreal aflibercept for macular edema following branch retinal vein occlusion: the 24-week results of the VIBRANT studyOphthalmology2015122353854425315663
   PubMed Web of Science ®Google Scholar
• SingerMABellDJWoodsPEffect of combination therapy with bevacizumab and dexamethasone intravitreal implant in patients with retinal vein occlusionRetina20123271289129422466480
   PubMed Web of Science ®Google Scholar
• ColenbranderAMeasuring vision and vision lossDuaneTDuane’s Clinical Ophthalmology5PhiladelphiaLippincott Williams & Wilkins2001139
   Google Scholar
• CaponeAJrSingerMADodwellDGEfficacy and safety of two or more dexamethasone intravitreal implant injections for the treatment of macular edema related to retinal vein occlusion (SHASTA study)Retina201434234235123846381
   PubMed Web of Science ®Google Scholar
• HeierJSClarkWLBoyerDSIntravitreal aflibercept injection for macular edema due to central retinal vein occlusion: two-year results from the COPERNICUS studyOphthalmology201412171414142024679444
   PubMed Web of Science ®Google Scholar
• HallerJABandelloFBelfortRJrRandomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusionOphthalmology201011761134114620417567
   PubMed Web of Science ®Google Scholar
• SingerMACaponeAJrDugelPUTwo or more dexamethasone intravitreal implants as monotherapy or in combination therapy for macular edema in retinal vein occlusion: subgroup analysis of a retrospective chart review studyBMC Ophthalmol2015153325885285
   PubMed Web of Science ®Google Scholar
• PinaJPTurkiKLabreucheJDuhamelATranTHEfficacy and safety in retinal vein occlusion treated with at least three consecutive intravitreal dexamethasone implantsJ Ophthalmol20162016601649127022479
   PubMed Web of Science ®Google Scholar
• MaturiRKChenVRaghinaruDBleauLStewartMWA 6-month, subject-masked, randomized controlled study to assess efficacy of dexamethasone as an adjunct to bevacizumab compared with bevacizumab alone in the treatment of patients with macular edema due to central or branch retinal vein occlusionClin Ophthalmol201481057106424940042
   PubMedGoogle Scholar
• MayerWJRemyMWolfAComparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edemaOphthalmologica2012228211011622739239
   PubMed Web of Science ®Google Scholar
• NarayananRPanchalBDasTChhablaniJJalaliSAliMHA randomised, double-masked, controlled study of the efficacy and safety of intravitreal bevacizumab versus ranibizumab in the treatment of macular oedema due to branch retinal vein occlusion: MARVEL report no 1Br J Ophthalmol201599795495925631483
   PubMed Web of Science ®Google Scholar
• RajagopalRShahGKBlinderKJBevacizumab versus ranibizumab in the treatment of macular edema due to retinal vein occlusion: 6-month results of the CRAVE studyOphthalmic Surg Lasers Imaging Retina201546884485026431300
   PubMed Web of Science ®Google Scholar
• YuanAAhmadBUXuDComparison of intravitreal ranibizumab and bevacizumab for the treatment of macular edema secondary to retinal vein occlusionInt J Ophthalmol201471869124634869
   PubMed Web of Science ®Google Scholar
• Diabetic Retinopathy Clinical Research NetworkAflibercept, bevacizumab, or ranibizumab for diabetic macular edemaN Engl J Med2015372131193120325692915
   PubMed Web of Science ®Google Scholar